Qingdao Haier Biomedical Co Ltd (688139) — Working Capital to Net Assets Ratio
Qingdao Haier Biomedical Co Ltd (688139) has a Working Capital to Net Assets ratio of 35.6% as of March 2026. Working capital of CN¥1.67 Billion (current assets of CN¥2.74 Billion minus current liabilities of CN¥1.07 Billion) is measured against net assets of CN¥4.70 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Qingdao Haier Biomedical Co Ltd (688139) financial flexibility to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Qingdao Haier Biomedical Co Ltd Working Capital to Net Assets (2016–2025)
This chart shows how Qingdao Haier Biomedical Co Ltd's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the ratio stands at 35.6%, reflecting working capital of CN¥1.67 Billion against net assets of CN¥4.70 Billion CNY. See Qingdao Haier Biomedical Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Qingdao Haier Biomedical Co Ltd (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Qingdao Haier Biomedical Co Ltd from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Qingdao Haier Biomedical Co Ltd (688139) total market value.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 34.0% | CN¥1.57 Billion | CN¥4.62 Billion | CN¥2.66 Billion | CN¥1.09 Billion | ▼ -1.3 pp |
| 2024 | 35.3% | CN¥1.63 Billion | CN¥4.62 Billion | CN¥2.65 Billion | CN¥1.02 Billion | ▼ -0.6 pp |
| 2023 | 35.9% | CN¥1.59 Billion | CN¥4.44 Billion | CN¥2.54 Billion | CN¥941.66 Million | ▼ -19.6 pp |
| 2022 | 55.5% | CN¥2.30 Billion | CN¥4.15 Billion | CN¥3.49 Billion | CN¥1.18 Billion | ▼ -8.0 pp |
| 2021 | 63.6% | CN¥2.31 Billion | CN¥3.64 Billion | CN¥3.46 Billion | CN¥1.14 Billion | ▲ +2.9 pp |
| 2020 | 60.7% | CN¥1.69 Billion | CN¥2.78 Billion | CN¥2.73 Billion | CN¥1.04 Billion | ▼ -21.3 pp |
| 2019 | 82.0% | CN¥2.02 Billion | CN¥2.46 Billion | CN¥2.56 Billion | CN¥545.78 Million | ▲ +9.3 pp |
| 2018 | 72.7% | CN¥809.90 Million | CN¥1.11 Billion | CN¥1.92 Billion | CN¥1.11 Billion | ▼ -8.0 pp |
| 2017 | 80.7% | CN¥496.23 Million | CN¥614.76 Million | CN¥1.07 Billion | CN¥570.69 Million | ▼ -7.5 pp |
| 2016 | 88.2% | CN¥637.70 Million | CN¥722.81 Million | CN¥855.69 Million | CN¥217.99 Million | — |